Comparison of cardioprotective effects of empagliflozin and vildagliptin

Autor: Volha Vasilkova, Ivan Pchelin, Tatsiana Mokhort

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c5b0d42097a03629648cf0448d8dcf0
https://doi.org/10.1530/endoabs.90.ep267

EARLY AND ALTERNATIVE MARKERS OF CHRONIC HEART FAILURE IN PATIENTS WITH DIABETES MELLITUS

Autor: N. Filiptsova, Ivan Pchelin, Y. Borovets, Y. Yarets, Tatiana Mokhort, Volha Vasilkova, Elena Naumenko, O. Shestovets, L. Korotaeva, Valentina Bayrasheva

Publikováno v: Emergency Cardiology and Cardiovascular Risks. 5:1122-1127

Aim: to assess the relationship of proinflammatory cytokines and chemokines with the levels of natriuretic peptides in patients with diabetes mellitus (DM). Materials and methods. A total of 155 patients (14 men and 61 women) with type 1 and type 2 d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1707eeec790dfc06a9f4eeba6533f756
https://doi.org/10.51922/2616-633x.2021.5.2.1122

MO403: The Association Between Urinary 11-Dehydrothromboxane B2 and Laboratory Parameters in Aspirin-Treated Patients With Cardiorenal Syndrome

Autor: Kseniia Lukianets, Volha Vasilkova, Ivan Pchelin, Alexander Shishkin

Publikováno v: Nephrology Dialysis Transplantation. 37

BACKGROUND AND AIMS Evaluation of urinary levels of the 11-dehydrothromboxane B2 is one of the methods for assessing platelet reactivity while taking aspirin. High levels of 11-dehydrothromboxane B2 in urine indicate continued thromboxane generation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86b3de8f97fcaea4580fb33313f17796
https://doi.org/10.1093/ndt/gfac070.017

MO640LASER DOPPLER FLOWMETRY IN STUDYING OF MICROVASCULAR DISORDERS IN PATIENTS WITH DIABETIC NEPHROPATHY

Autor: Petr Vasilev, Nikolai P. Erofeev, Alexander Shishkin, Ivan Pchelin, Mikhail V. Erman

Publikováno v: Nephrology Dialysis Transplantation. 36

Background and Aims According to various research, vascular complications of type 2 diabetes mellitus are the main reason for patients' mortality. The most specific one, observed in patients with diabetes only, is diabetic microangiopathy, especially

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87fe8a80d1529358ea9aa4fba912115b
https://doi.org/10.1093/ndt/gfab094.008

Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study

Autor: Valentina Bayrasheva, Vladimir Dobronravov, Volha Vasilkova, Ivan Pchelin, Svetlana Chefu, Alina Babenko, Natalia Hudiakova, Pavel A. Andoskin, Ivan S. Shatalov, Alexandra N. Ivanova, Elena N. Grineva

Publikováno v: Archives of Endocrinology and Metabolism, Issue: ahead, Published: 06 APR 2020
Archives of Endocrinology and Metabolism, Vol 64, Iss 4, Pp 418-426 (2020)
Archives of Endocrinology and Metabolism, Volume: 64, Issue: 4, Pages: 418-426, Published: 06 APR 2020
Archives of Endocrinology and Metabolism v.64 n.4 2020
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM

Objective The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. Subjects and methods We randomized 47 insulin-tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df769895d0b5d84e5a7a3edf8c2de15
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020005002202&lng=en&tlng=en